This week, you will create a Medication Study Guide to share with your peers. This guide is intended to be a useful learning tool for you to use as you prepare for your clinical courses.
You will be assigned one of the following medications to create your guide:
| Chlorpromazine | Fluphenazine | Haloperidol | Loxapine | Perphenazine |
| Aripiprazole | Asenapine | Clozapine | Iloperidone | Olanzapine |
| Paliperidone | Quetiapine | Risperidone | Ziprasidone | Lurasidone |
| Brexpiprazole | Cariprazine | Lumateperone | Benztropine | Propranolol |
| Deutetrabenazine | Valbenazine |
|
PREPARING FOR THE ASSIGNMENT
- Identify your assigned psychotropic medication agent.
- Review this week’s Learning Resources, including the medication resources indicated for this week.
- Reflect on the psychopharmacologic treatments you might recommend for the assessment and treatment of vulnerable patient populations requiring antidepressant therapy.
THE ASSIGNMENT
Create a 3- to 4-page (excluding visual elements) Medication Study Guide for your assigned psychotropic medication agents that may be utilized by you and colleagues for study. Your medication guide should be in the form of an outline and should include a title page, citations, and references. You should incorporate visual elements, such as concept maps, charts, diagrams, images, color coding, mnemonics, and/or flashcards. Be creative!
Note: Your Medication Study Guide should not be in the format of an APA paper.
Also Note: Your guide should be informed by the FDA-Approved and Evidenced-Based, Clinical Practice Guidelines Research.
Areas of importance that you should address—but are not limited to—include:
- Title page
- Description of the psychopharmacological medication agent, including brand and generic names, as well as appropriate FDA indication uses
- Any supporting, valid, and reliable research for non-FDA uses
- Drug classification
- The medication mechanism of action
- The medication pharmacokinetics
- The medication pharmacodynamics
- Appropriate dosing, administration route, and any considerations for dosing alterations
- Considerations of use and dosing in specific specialty populations, such as children, adolescents, elderly, pregnant people, those exhibiting suicidal behaviors, etc.
- Definition of half-life, why half-life is important, and the half-life for your assigned medication
- Side effects/adverse reactions potential
- Discuss clinical concerns with EPS and Tardive Dyskinesia
Note:Be sure to include screening tools that would be utilized. - Contraindications for use including significant drug to drug interactions
- Overdose considerations
- Diagnostics and labs monitoring comorbidities considerations
- Legal, ethical, and social considerations
- Pertinent patient education considerations
- References page
Support your rationale with a minimum of three (3) academic resources.
Note: While you may use the course text to support your rationale, it will not count toward the resource requirement. You should be utilizing primary and secondary literature.
DAY 7 OF WEEK 7
You will need to submit your Assignment to two places:
- Week 7 Medication Guide Discussion forum (linked at the button below) as an attachment
- Week 7 Medication Guide Assignment submission link
Although no responses are required in the Discussion forum, collegial Discussion is welcome. You are encouraged to utilize your peers’ submitted guides on their assigned medication for study.
SOLUTION:
How to Take Lurasidone Properly
The second-generation antipsychotic lurasidone (brand name: Latuda) controls the activity of the dopamine (D2) and serotonin (5-HT2A) receptors, which have a role in some mental disorders. For the treatment of schizophrenia in adults and adolescents (13–17 years old), lurasidone has been approved by the Food and Drug Administration(Miura et al., 2023). Adults, adolescents, and children aged 10 and above may take it for bipolar affective disorder, particularly during depressive episodes (Azhar & Shaban, 2023). Nevertheless, lurasidone’s Additional study is necessary to determine its potential value in the treatment of mood and anxiety disorders. Nonetheless, the FDA has not yet authorized such uses.
| Category | Indications |
| FDA Approved Uses | – schizophrenia treatment |
| – Managing manic-depressive episodes | |
| Non-FDA Uses | – Off-label treatment for severe depression |
| – Potential treatment of anxiety disorders | |
| – Therapeuticuses in treatment-resistant schizophrenia |
Table 1: FDA and Other Users’ Instances
Classification of Drugs
One class of antipsychotics is the second generation, and lorazepam is one of them. At this time, it is recommended for the management of mental health issues such as bipolar disorder and schizophrenia. Several brain receptors are involved in the reuptake of dopamine and serotonin, which is how lurasidone, an unconventional antipsychotic medication, operates. According to Goldin (2023), lurasidone seems to work by blocking the dopamine D2 and serotonin 5-HT2A receptors, which gives it its therapeutic effects for symptoms including psychosis, paranoid delusions, hallucinations, emotional incongruities, and cognitive impairment……………….KINDLY CLICK ON THE PURCHASE ICON BELOW TO ACCESS THE ENTIRE SOLUTION FOR $15